[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.175.236. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Commentary
Jan 23, 2012

Strategies for Reducing Colorectal Cancer Among Blacks

Author Affiliations

Author Affiliations: Harold C. Simmons Cancer Center (Drs Gupta and Balasubramanian), Divisions of Digestive and Liver Diseases (Dr Gupta) and Outcomes and Health Services Research (Dr Gupta), and Departments of Internal Medicine (Drs Gupta and Shah) and Clinical Sciences (Dr Gupta), UT Southwestern Medical Center, Dallas, Texas; Parkland Health and Hospital System, Dallas (Drs Gupta and Shah); and University of Texas School of Public Health, Dallas Regional Campus (Dr Balasubramanian).

Arch Intern Med. 2012;172(2):182-184. doi:10.1001/archinternmed.2011.594

Blacks have the highest colorectal cancer (CRC) incidence and mortality of any racial/ethnic group in the United States.1 Indeed, at every age, CRC incidence is higher for blacks than for non-Hispanic whites (Figure). Differences in CRC incidence and mortality have been attributed to poor access to care, failure of physicians to recommend CRC screening, and low rates of participation when screening is offered, as well as possible differences in tumor characteristics and genetics among blacks compared with other groups.2,3

First Page Preview View Large
First page PDF preview
First page PDF preview
×